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This study was designed to evaluate the effects of meta-
raminol (Aramine) in six patients with evolving acute
inferior wall myocardial infarction accompanied by hy-
potension and warm limbs. There were 16 episodes of
acute inferior wall ischemia, and the response to therapy
wasjudged by evaluating blood pressure and ST segment
and T wave abnormalities. Three patients received in-
travenous isosorbide dinitrate and two received strep-
tokinase as the initial therapy. The mean ST segment
elevation was significantly reduced (from 4.94 ± 1 to
0.5 ± 0.7 [p < 0.0001]) after metaraminol infusion was
initiated. The average T wave height also decreased (from
6.8 ± 2 to - 1.3 ± 2.5 mm [p < 0.0005]). The average
heart rate decreased from 82 ± 11 to 69 ± 9 beats/min
(p < 0.05) and the mean arterial blood pressure in-
creased from 81 ± 12mm Hg before metaraminol treat-
ment to 126 ± 8 mm Hg after treatment. All these
Previous experimental studies (1-3) have demonstrated the
beneficial effect of alpha-adrenergic agonists in reducing
ischemic injury in experimental acute myocardial infarction
in dogs . These findings have been extended to humans (4,5).
Borer et al. (4) demonstrated reduction in myocardial isch-
emia in seven patients during acute myocardial infarction
without heart failure by using phenylephrine to abolish ni-
troglycerin-induced hypotension.
The present study was undertaken to determine the ef-
fectiveness of therapy with metaraminol (Aramine) on the
extent of ischemic injury in six patients with acute inferior
wall myocardial infarction accompanied by hypotension and
peripheral vasodilation.
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changes occurred within a few minutes after metaram-
inol therapy was instituted. In 12 episodes, accelerated
idioventricular rhythm appeared concomitantly with the
resolution of ST segment elevation.
Coronary angiography performed between 4 and 10
days after admission demonstrated significant obstruc-
tion in all infarct-related arteries, but none was totally
occluded. Left ventricular function was normal in three
patients and slightly hypokinetic in the inferior wall in
two.
These results indicate that in a selected group of pa-
tients with acute inferior myocardial infarction, meta-
raminol administration (in certain hemodynamic cir-
cumstances) can alleviate acute ischemia within a few
minutes and thereby reduce ischemic injury.
(J Am Coli Cardiol 1987;10:1139-44)
Methods
Study patients. Between February 1985 and March 1986,
106 patients were admitted to our intensive coronary unit
with evidence of acute inferior acute myocardial infarction.
Of these 106 patients , 6 (6%) fulfilled the criteria defined
later for metaraminol therapy , and these patients formed the
study group . There were two men and four women (range
40 to 73 years, mean 58) . The onset of symptoms (chest
pain) occurred I to 4 hours before the study.
Study protocol. According to our standard protocol. all
patients who presented in the hyperacute phase of acute
myocardial infarction received intravenous isosorbide di-
nitrate (provided that systolic blood pressure was > 100 mm
Hg and heart rate was < 110 beats/min) and a continuous
drip infusion of heparin sulfate . From December 1985, we
started to give intravenous streptok inase, according to the
protocol used by Ganz et al. (6); thus two patients in this
study group received intravenous streptokinase as initial
therapy. One patient who presented with hypotension re-
ceived metaraminol as initial therapy,
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Metaraminol wasadministered only to patients whoful-
filledall thefollowing criteria: 1) ST segment elevation and
a positive T wave without a Q wave in leads II, III and aVF
during severe chest pain; 2) systolic blood pressure <90
mm Hg; 3) warm limbs; 4) no signs of heart failure; and 5)
no clinical, electrocardiographic and echocardiographic signs
of right ventricular infarction.
Metaraminol infusion (40 mg in 100 ml saline solution)
began at a rate of 2 drops/min and the rate was increased
rapidly to raise the systolic arterial pressure by 30 mm Hg.
Systolic blood pressure was not allowed to exceed 130 mm
Hg. Continuous electrocardiographic monitoring of the in-
ferior lead that showed maximal ST segment elevation was
done during the ischemic episode. Cuff blood pressures were
recorded at intervals of 0.5 to 1 minute. The magnitude of
ST segment elevation, T wave height and heart rate were
recorded continuously. Metaraminol infusion was continued
to maintain systolic blood pressure at approximately 120
mm Hg until the acute ischemic episode subsided and then
was gradually stopped.
Angiographic data. Biplane left ventriculography and
selective arteriography of both coronary arteries were per-
formed in five patients because of recurrent ischemic epi-
sodes within 4 to 10 days after admission. Coronary stenosis
of >70% of luminal diameter in any view was considered
significant.
Statistical analysis. A paired t test was used to compare
each of the hemodynamic and electrocardiographic variables
before and after administration of metaraminol. Differences
were considered statistically significant at the p < 0.05
level. The time course of each hemodynamic and electro-
cardiographic variable was demonstrated in adequate curves;
for each time point, the mean value ± I standard deviation
was calculated.
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Figure 1. Changes in ST segment elevation in six patients with
16 ischemic episodes before and during metaraminol administra-
tion. Metaraminol produced a marked reduction in ST segment
level.
Heart rate and arrhythmias. Administration of meta-
raminol decreased the average heart rate from 82 ± 11 to
69 ± 9 beats/min (p < 0.05), but in five episodes, the heart
rate was unaltered (Fig. 3). In 12 episodes, accelerated
idioventricular rhythm appeared concomitantly with the res-
olution of ST segment elevation (Fig. 4 and 5).
Blood pressure. The mean blood pressure before meta-
raminol was 81 ± 12 mm Hg, and increased to 125 ± 8
mm Hg (p < 0.0005) during drug infusion (Fig. 6). The
increase in systolic blood pressure was noticable within 0.5
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Figure 2. Time course of mean ST segment elevation during
metaraminol infusion. There is a dramatic reduction in mean (M)
ST segment level starting after 0.5 minute.
The six patients had a total of 16 acute ischemic episodes
during the early stages of the acute myocardial infarction
(two to four episodes for each patient). The effects of meta-
raminol on electrocardiographic variables, blood pressure
and heart rate during each ischemic episode are presented
in Figures 1 to 6.
Electrocardiographic variables. The mean ST segment
elevation of the 16 ischemic episodes was significantly re-
duced (from 4.9 ± 1.2 to 0.5 ± 0.72 mm [p < 0.0001])
after metaraminol therapy (Fig. 1). The decrease in ST
segment elevation was noticeable within 0.5 to 6 minutes
after initiation of the metaraminol infusion (Fig. 2). The
mean T wave height also decreased (from 6.8 ± 2 to 1.3
± 2 mm [p < 0.0005]) during metraminol infusion and
this decrease was noticeable within 0.5 to 6 minutes after
initiation of therapy.
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HR
Figure 3. Changes in heart rate (HR) in six patients with 16
ischemic episodes during metaraminol administration.
Figure 5. Influence of isosorbide dinitrate and metaraminol on
ST segment elevation in a 73 year old woman with acute inferior
myocardial infarction. Isosorbide dinitrate administration during
40 minutes caused a decrease in blood pressure (BP) and an in-
crease in ST segment elevation. Metaraminol administration caused
a rapid decrease in ST segment elevation within 5 minutes and the
appearance of accelerated idioventricular rhythm (115 beats/min)
after 25 minutes.
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to 2 minutes (Fig. 4 and 5). In three patients. the low systolic
blood pressure occurred during isosorbidedinitrate infusion.
and in two patients during streptokinase therapy. One patient
presented with hypotension before starting any drug therapy.
There was an inverse relation between blood pressure and
Figure 4. Influence of streptokinase and metaraminol on ST seg-
ment elevation in a 40 year old woman with acute inferior myo-
cardial infarction. A, Streptokinase administration caused a de-
crease in blood pressure. but did not reduce ST segment elevation
within 50 minutes. B, Metaraminol administration caused a de-
crease in ST elevation and bradycardia (40 beats/min) within 2
minutes. C, Accelerated ventricular rhythm (85 beats/min) ap-
peared after 5 minutes. D, Nearly complete resolution of ST seg-
ment elevation appeared 20 minutes after metaraminol adminis-
tration. BP blood pressure.
5 I. 1 .\" I I I
the extent of ST segment elevation (Fig. 4). When blood
pressure increased. there was a concomitant decrease in ST
segment level (r = 0.9151).
Angiographic findings. The right coronary artery was
significantly obstructed in four patients. and the circumflex
artery was obstructed in one patient. None of these infarct-
related arteries was totally obstructed. and there was anter-
ograde flow. There was no evidence of thrombus. Two
patients also had significant left anterior descending coro-
nary artery disease. Biplane left ventriculography revealed
normal left ventricular function in three patients and slight
inferior hypokinesia in the remaining two patients.
Figure 6. Relation between the ST segment level and systolic
blood pressure (BP) before and during metaraminol infusion in 16
ischemic episodes. There is an inverse relation between the ST
segment level and blood pressure (r = - 0.915 I).
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Follow-up. Two patients underwent successful angio-
plasty and three underwent coronary artery bypass surgery.
All six patients are free of symptoms with no sign of heart
failure.
Discussion
Rapid resolution of ST segment elevation as a marker
of reperfusion. The results of this investigation show that
administration of metaraminol in a selectedgroupof patients
with acute inferior myocardial infarction accompanied by
hypotension can dramatically reduce ST segment elevation
and T wave height within a few minutes. It is well recog-
nized that acute ST segment changes can serve as an index
of subsequent ischemic damage, and that a decrease in the
magnitude of ST segment elevation reflects a reduction in
the ischemic injury to the myocardium. A rapid decrease in
ST segment elevation is one of the manifestations of re-
perfusion induced by intracoronary thrombolytic therapy
(6-8) . It has also been shown to be a reliable noninvasive
markerof reperfusion during intravenous thrombolytic ther-
apy (9). Recently, Hackworthy et al. (l0) found a relation
between.the rate of resolution of ST segment elevation and
the degree of perfusion of the infarct artery in patients with
acute myocardial infarction in the absence of therapeutic
intervention. They alsodemonstrated that a relationbetween
the rate of decline in ST segment elevation and the time to
peak level of serum creatine kinase, which is further evi-
dence that the rate of resolution of ST segment elevation
reflects myocardial perfusion. In their 19patientswith acute
inferior myocardial infarction, spontaneous ST segmentres-
olution occurred between 2 and 8 hours.
Ganz et al. (9) demonstrated that ST segment resolution
was achieved 36 ± 26 minutes after the start of intravenous
streptokinase infusion in evolving acute myocardial infarc-
tion. According to our experience and that of others (11),
with administration of intravenous nitrates during acute
myocardial infarction, it takes at least 15 minutes for the
ST segment to decrease significantly . Goldet al. (12) showed
a 77 ± 8% decrease in ST segment elevation within 30
minutes after the administration of intravenous propranolol
in seven patients with acute anterior wall infarction . Lein-
bach et al. (13) showed an 84% decrease in ST segment
elevation after I hour in five patients by using an intraaortic
balloon pump during acute myocardial infarction without
shock. None of the interventions just described, however,
produce ST segment resolution in as short a time as shown
in our study.
Effect of metaraminol. Previous experimental studies
(1-3) have demonstrated the beneficial effect of alpha-ad-
renergicagonists such as methoxamine in reducingischemic
injury in experimental acute myocardial infarction in dogs.
In these experiments, the alpha-adrenergic agonists were
used in addition to nitroglycerin to prevent the decrease in
blood pressure and reflex tachycardia. Borer et al. (4) ex-
tended this finding to humans and demonstrated a reduction
in myocardial ischemia by using intravenous nitroglycerin
in combination with phenylephrine only in patients without
heart failure.
In our study, we used metaraminol , which is predomi-
nantly an alpha-adrenergic agonist. Its overall effects are
similar to those of norepinephrine , but it is much less potent
(14) . The cardiovascular actions in human patients are re-
flected in a sustained increase in systolic and diastolic pres-
sures due almost entirely to vasoconstriction and usually
accompanied by a marked reflex bradycardia. Its action on
beta-receptors in the myocardium is less prominent than
thatof other sympathomimetic aminessuchas isoproterenol,
which act mainly on beta-receptors. Although dopamine in
highdosescausesvasoconstriction-an action similar to that
of metaraminol-it still exerts a positive inotropic and
chronotropic effect on the myocardium. which frequently
causes tachycardia (14) . In our experience, tachycardia or
other tachyarrhythmias are very rare with the use of meta-
raminol.
How metaraminol acts on the coronary circulation in
humans is unclear. but it is known to increase coronary
blood flow in dogs (15). Metaraminol was used in 12 pa-
tients during acute myocardial infarction in 1964by Malm-
crona et al. (16). who demonstrated an increase in blood
pressure, a decrease in heart rate and a higherstroke volume
duringmetaraminol infusion, hemodynamic changes similar
to those observed in our study group. However, these in-
vestigators made no comment on electrocardiographic
changes.
Patient selection. The selection of appropriate candi-
dates for metaraminol therapy was done carefully because
of the well known risk of aggravating ischemic injury by
administration of sympathomimetic amines. We excluded
patients with heart failure because it was shown experi-
mentally (17) and in human patients (4) that elevation of
systemic arterial pressure above normal levels can result in
the extension of ischemic injury. Patients with peripheral
vasoconstriction were also excluded because any further
increase in vasoconstriction is unnecessary and can be harm-
ful. Thus, metaraminol therapy was instituted only if the
patients were hypotensive , in the hyperacute phase of acute
inferior myocardial infarction without peripheral vasocon-
striction and heart failure and if there was no clinical sign
of right ventricular infarction. We did not observe similar
patients with acute anterior myocardial infarction.
Theoretical consideration of the effect of metaraminol
on ischemia. In all of our patients, the ischemic episodes
were probably a consequence of reduction in flow , rather
than increase in demand (there was no hypertension or
tachycardia in any patient). The acceptedtheoriesexplaining
the reduction of flow during acute myocardial infarctionare:
I) mechanical-coronary thrombosis usually superimposed
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on a discrete atherosclerotic coronary stenosis (18); and 2)
dynamic coronary obstruction-whether by active constric-
tion (coronary spasm) or passive collapse,
Maseri et aL (19,20) postulated that vessel occlusion with
interruption of distal flow can occur only when tonc is in-
creased, Ganz (21) postulated that a drastic reduction in
flow can occur in a severely stenosed artery as a result of
a decrease in distending pressure causing passive collapse
of the vessel. The causes of passive change in stenotic area
could be: I) a decrease in perfusion pressure (hypotension)
that leads to an increased resistance to flow across a stenotic
artery (22), and 2) coronary arteriolar dilation (whether the
result of augmentation of myocardial oxygen demand or
application of vasodilators) and decrease in resistance distal
to an elastic stenosis, which causes a decrease in distal
coronary artery and distending pressures, thereby increasing
the stenosis and the resistance to flow (23,24L
The dramatic effect of metaraminol in our studv could
possibly be explained by the' 'passive collapse' theory, In
our patients, isosorbide dinitrate administration caused a
decrease in systolic blood pressure (decreased perfusion
pressure) and possibly coronary arteriolar dilation (de-
creased resistance) and hence a passive collapse, By giving
metaraminol, we raised the blood pressure and coronary
perfusion pressure and opened the collapsed artery. The
rapid resolution of the ST segment elevation indicates re-
perfusion, The appearance of accelerated idioventricular
rhythm in five patients concomitantly with resolution of ST
segment elevation further supports reperfusion (25), If coro-
nary spasm was the underlying mechanism causing ischemia
in our patients, one would expect metaraminol, a potent
vasoconstrictor, to aggravate it. Another possible expla-
nation of the beneficial effect of metaraminol could be the
significant slowing of heart rate and subsequent reduction
in myocardial oxygen demand, However, the fact that the
heart rate was unaltered in five episodes despite a dramatic
ST segment resolution is contrary to this explanation.
In three of our patients, hypotension could have been
caused by nitrate administration, and in two other patients,
by streptokinase therapy, Although we cannot exclude the
possibility that the beneficial effects observed are, indeed,
due to the combined effect of metaraminol and isosorbide
dinitrate or streptokinase therapy, the almost immediate re-
sult observed with metaraminol strongly implies that the
beneficial effects were mainly related to this agent. This is
well exemplified in the representative cases (Fig, 4 and 5),
In addition, in one patient who received only metaraminol.
results were similar to those in the other patients,
Angiographic and ventricular data. In all patients, the
infarct-related artery was severely obstructed (90 to 95%)
but still patent. As stated before, passive collapse can occur
only in severely stenosed arteries, There was no evidence
of thrombus formation, and it could be speculated that by
increasing the distending pressure, the thrombus was being
washed distally and its formation was prevented, The fact
that every time the blood pressure decreased there was an
increase in ST segment elevation makes it unlikely that
thrombus formation was the primary event.
Three patients had normal left ventricular function and
two had only slight hypokinesia in the inferior wall on
ventriculography4 to I()days after the acute episodes, which
can be ascribed to the shortening of the ischemic period by
metaraminol infusion,
Limitations of study. Our study has not provided suf-
ficient hemodynamic data to explain the observed beneficial
effects of intravenous metaraminol. Procedures such as an
arterial line and a Swan-Ganz catheter were not done be-
cause of the dramatic nature of the ischemic episodes and
the immediate response to metaraminol infusion, Because
of the preliminary nature of these results, we are currently
conducting a prospective clinical trial that will include all
the hemodynamic variables on a larger group of patients
with acute myocardial infarction in other sites,
Clinical application. Our results indicate that in a highly
selected group of patients with acute inferior wall myo-
cardial infarction, metaraminol administration, if properly
used, can alleviate acute ischemia within a few minutes and
thereby reduce ischemic injury, Our documentation of the
absence of a deleterious effect of this drug is also of great
importance because other agents causing greater accelera-
tion of heart rate or vasoconstriction, or both, may exac-
erbate ischemic injury, Our study also provides clinical sup-
port to the "passive collapse" theory and thereby contributes
to the current controversy concerning the mechanism of
dynamic coronary obstruction,
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